Kevin Kozak

Person

Madison, WI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Luminescent phospholipid analogs for the identification and isolati...
- Patent number 11,467,159
- Issue date Oct 11, 2022
- CELLECTAR BIOSCIENCES, INC.
- Jamey P. Weichert
- G01 - MEASURING TESTING
Information Patent Grant
Phospholipid ether analogs as cancer-targeting drug vehicles
- Patent number 11,439,709
- Issue date Sep 13, 2022
- CELLECTAR BIOSCIENCES, INC.
- Jamey P. Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phospholipid ether analogs as cancer-targeting drug vehicles
- Patent number 9,925,269
- Issue date Mar 27, 2018
- CELLECTAR BIOSCIENCES, INC.
- Jamey P. Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alkylphosphocholine analogs for multiple myeloma imaging and therapy
- Patent number 9,925,283
- Issue date Mar 27, 2018
- Wisconsin Alumni Research Foundation
- Jamey Paul Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phospholipid ether analogs as cancer-targeting drug vehicles
- Patent number 9,480,754
- Issue date Nov 1, 2016
- CELLECTAR BIOSCIENCES, INC.
- Jamey P. Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phospholipid ether analogs as cancer-targeting drug vehicles
- Patent number 9,345,718
- Issue date May 24, 2016
- CELLECTAR BIOSCIENCES, INC.
- Jamey P. Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles
- Publication number 20180333498
- Publication date Nov 22, 2018
- Cellectar Biosciences, Inc.
- Jamey P. Weichert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-DRUG COMBINATIONS THAT ACT AS POTENT RADIOSENSITIZERS
- Publication number 20180153849
- Publication date Jun 7, 2018
- Wisconsin Alumni Research Foundation
- Glen S. KWON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHOLIPID ETHER ANALOGS FOR THE IDENTIFICATION AND ISOLATION OF...
- Publication number 20170356914
- Publication date Dec 14, 2017
- Cellectar Biosciences, Inc.
- Jamey P. Weichert
- G01 - MEASURING TESTING
Information Patent Application
ALKYLPHOSPHOCHOLINE ANALOGS FOR MULTIPLE MYELOMA IMAGING AND THERAPY
- Publication number 20160296646
- Publication date Oct 13, 2016
- Wisconsin Alumni Research Foundation
- Jamey Paul Weichert
- G01 - MEASURING TESTING
Information Patent Application
Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles
- Publication number 20160228564
- Publication date Aug 11, 2016
- Cellectar Biosciences, Inc.
- Jamey P. Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles
- Publication number 20160136190
- Publication date May 19, 2016
- Cellectar Biosciences, Inc.
- Jamey P. Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles
- Publication number 20160136290
- Publication date May 19, 2016
- Cellectar Biosciences, Inc.
- Jamey P. Weichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kevin Kozak

Person

Patents Grantslast 30 patents

Luminescent phospholipid analogs for the identification and isolati...

Phospholipid ether analogs as cancer-targeting drug vehicles

Phospholipid ether analogs as cancer-targeting drug vehicles

Alkylphosphocholine analogs for multiple myeloma imaging and therapy

Phospholipid ether analogs as cancer-targeting drug vehicles

Phospholipid ether analogs as cancer-targeting drug vehicles

Patents Applicationslast 30 patents

Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles

MULTI-DRUG COMBINATIONS THAT ACT AS POTENT RADIOSENSITIZERS

PHOSPHOLIPID ETHER ANALOGS FOR THE IDENTIFICATION AND ISOLATION OF...

ALKYLPHOSPHOCHOLINE ANALOGS FOR MULTIPLE MYELOMA IMAGING AND THERAPY

Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles

Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles

Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles